To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Mature glycoprotein g pre… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.

Journal article
Authors Staffan Görander
Judica Mbwana
Eligius Lyamuya
Teresa Lagergård
Jan-Åke Liljeqvist
Published in Clinical and vaccine immunology : CVI
Volume 13
Issue 6
Pages 633-9
ISSN 1556-6811
Publication year 2006
Published at Institute of Biomedicine, Department of Microbiology and Immunology
Institute of Biomedicine, Department of Infectious Medicine
Pages 633-9
Language en
Links dx.doi.org/10.1128/CVI.00051-06
Keywords Adolescent, Adult, Age Factors, Animals, Antibody Specificity, Blotting, Western, methods, Cells, Cultured, Cohort Studies, Enzyme-Linked Immunosorbent Assay, methods, Female, Herpes Genitalis, blood, diagnosis, epidemiology, immunology, Herpesvirus 2, Human, immunology, isolation & purification, Humans, Infection, Male, Middle Aged, Sensitivity and Specificity, Seroepidemiologic Studies, Sex Factors, Tanzania, epidemiology, Viral Envelope Proteins, classification, diagnostic use, immunology, isolation & purification
Subject categories Medical and Health Sciences

Abstract

Herpes simplex virus type 2 (HSV-2) is a common sexually transmitted infection in sub-Saharan Africa. Glycoprotein G (gG) of HSV-2 elicits a type-specific antibody response and is widely used for serodiagnosis. gG is cleaved into a secreted portion (sgG-2) and a highly O-glycosylated mature portion (mgG-2). The performances of these two native immunosorbent purified antigens were compared in an enzyme-linked immunosorbent assay (ELISA) format with a commercially available assay (FOCUS2) using sera from blood donors (n = 194) and individuals (n = 198) with genital ulcer disease (GUD) from Tanzania. Discordant results were resolved by Western blotting. The HSV-2 seroprevalence for blood donors was estimated as 42%, and that for the GUD cohort was estimated as 78%. The prevalence increased significantly with age for both cohorts and was higher among human immunodeficiency virus (HIV)-positive individuals than among HIV-negative subjects. In the GUD cohort with a high HSV-2 prevalence, all three assays showed statistically similar performances, with sensitivities between 97% and 99% and specificities in the range of 86% to 91%. In contrast, among blood donors with a lower seroprevalence, the mgG-2-based ELISA presented significantly higher specificity (97%) than the sgG-2 ELISA (89%) and FOCUS2 (74%). Overall, the mgG-2 ELISA gave a high performance, with negative and positive predictive values of 96% for blood donors and a negative predictive value of 95% and a positive predictive value of 97% for the GUD cohort. We conclude that native purified mgG-2 showed the highest accuracy for detection of HSV-2 in patient sera from Tanzania and is therefore suitable for seroprevalence studies as well as in clinical settings.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?